JO
Insider
Jude Onyia
Chief Scientific OfficerJude Onyia (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $1.8M of NBIX (11,000 sh × $160.25, as filed), executed Jun 1.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.5M
shares × price, as filed
Last traded
Jun 1
Filed Jun 2
Median ADV $194.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $14.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
NBIX
Neurocrine Biosciences, Inc.
NBIX · 0 buys · 6 sells
6 filings
Recent filings
NBIXSALE
Neurocrine Biosciences, Inc.
View filing →
$1.8M11,000 sh × $160.25
Exec Jun 1
Filed Jun 2 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $1.7M
11,000 sh × $155.53
Exec May 27
Filed May 29 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $7.8M
59,819 sh × $130.46
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $2.6M
20,362 sh × $130.13
Exec Jul 2 2025
Filed Jul 7 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $336K
2,879 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $294K
2,331 sh × $126.29
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET